Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Liquidia Corporation is a biotechnology business based in the US. Liquidia Corporation shares (LQDA) are listed on the NASDAQ and all prices are listed in US Dollars. Liquidia Corporation employs 64 staff and has a market cap (total outstanding shares value) of USD$113.7 million.
|Latest market close||USD$3.13|
|52-week range||USD$2.53 - USD$12.1|
|50-day moving average||USD$3.2494|
|200-day moving average||USD$5.2717|
|Wall St. target price||USD$5.2|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-2.509|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-07)||1.95%|
|1 month (2020-12-17)||1.29%|
|3 months (2020-10-15)||4.68%|
|6 months (2020-07-15)||-52.58%|
|1 year (2020-01-15)||-47.48%|
|2 years (2019-01-15)||-80.71%|
|3 years (2018-01-13)||N/A|
|5 years (2016-01-13)||N/A|
Valuing Liquidia Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Liquidia Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Liquidia Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 4x. In other words, Liquidia Corporation shares trade at around 4x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
|Gross profit TTM||USD$7.3 million|
|Return on assets TTM||-49.81%|
|Return on equity TTM||-137.14%|
|Market capitalisation||USD$113.7 million|
TTM: trailing 12 months
There are currently 1.3 million Liquidia Corporation shares held short by investors – that's known as Liquidia Corporation's "short interest". This figure is 24.5% down from 1.8 million last month.
There are a few different ways that this level of interest in shorting Liquidia Corporation shares can be evaluated.
Liquidia Corporation's "short interest ratio" (SIR) is the quantity of Liquidia Corporation shares currently shorted divided by the average quantity of Liquidia Corporation shares traded daily (recently around 1.4 million). Liquidia Corporation's SIR currently stands at 0.94. In other words for every 100,000 Liquidia Corporation shares traded daily on the market, roughly 940 shares are currently held short.
However Liquidia Corporation's short interest can also be evaluated against the total number of Liquidia Corporation shares, or, against the total number of tradable Liquidia Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Liquidia Corporation's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Liquidia Corporation shares in existence, roughly 30 shares are currently held short) or 0.0321% of the tradable shares (for every 100,000 tradable Liquidia Corporation shares, roughly 32 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Liquidia Corporation.
Find out more about how you can short Liquidia Corporation stock.
We're not expecting Liquidia Corporation to pay a dividend over the next 12 months.
Over the last 12 months, Liquidia Corporation's shares have ranged in value from as little as $2.53 up to $12.1. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Liquidia Corporation's is 0.0238. This would suggest that Liquidia Corporation's shares are less volatile than average (for this exchange).
Liquidia Corporation, through its subsidiaries, operates as a late-stage clinical biopharmaceutical company. The company focuses on the development and commercialization of various products using its PRINT technology that enables precise production of drug particles designed to enhance the safety, efficacy, and performance of a range of therapies. Its product candidates include LIQ861 for the treatment of pulmonary arterial hypertension; and LIQ865 for the treatment of local post-operative pain. The company also provides strategy, investment, and commercialization services for rare disease pharmaceutical products, such as generic Remodulin, a parenteral formulation of treprostinil for pulmonary arterial hypertension. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina.
Everything we know about the Gold Royalty Corp IPO, plus information on how to buy in.
Everything we know about the Bustle Digital Group IPO, plus information on how to buy in.
Everything we know about the Lucid Motors IPO, plus information on how to buy in.
Steps to owning and managing HFFG, with 24-hour and historical pricing before you buy.
Steps to owning and managing HASI, with 24-hour and historical pricing before you buy.
Steps to owning and managing GRIF, with 24-hour and historical pricing before you buy.
Steps to owning and managing FSBW, with 24-hour and historical pricing before you buy.
Steps to owning and managing FNWB, with 24-hour and historical pricing before you buy.
Steps to owning and managing FXNC, with 24-hour and historical pricing before you buy.
Steps to owning and managing FMNB, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.